Comparison of ticagrelor and clopidogrel in the treatment of patients with coronary heart disease carrying CYP2C19 loss of function allele
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thoracic Disease"
DOI: 10.21037/jtd-22-740
Abstract: Background Clopidogrel is a traditional P2Y12 receptor inhibitor that is widely used in clinical practice, but there are significant individual differences in its therapeutic effect. Carriers of the CYP2C19 deletion allele have a higher risk… read more here.
Keywords: ticagrelor; prognosis; ticagrelor clopidogrel; disease ... See more keywords
Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2018.00689
Abstract: Caveolin-1 (CAV1) variants have been suggested to be associated with obesity and related metabolic disorders, but information based on human studies is limited. In the present study, we aimed to investigate the potential association between… read more here.
Keywords: variant; group; kuwaiti children; intermediate metabolic ... See more keywords